(via TheNewswire)

Vancouver, British Columbia – TheNewswire - January 2 1 , 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that conducts clinical health research and has developed a world first AI prediction tool for drug and alcohol intoxication detection using voice, is pleased to announce the Company has launched an extended showcase of its Voice and AI powered intoxication detection technology in the USA.  The showcase comes as the Company lists its common shares for trading on the OTCQB Market.

The Company has developed and commercialised a technology, activated by the voice and powered by AI to predict intoxication.  The Company has amassed large amounts of data from drug and alcohol clinical trials and has developed proprietary algorithms as the basis for its prediction technologies with remarkable accuracy for the detection of alcohol and hallucinogenic drugs.

The Company intends to expand its intoxication detection technologies to detect other prohibited drugs that are difficult to detect particularly at scale and volume and require specialised equipment, with MindBio’s solution provided by a simple analysis of the voice.

The voice analytics solution being developed by MindBio is a game changer for intoxication detection in workplace environments, particularly where drug and alcohol testing is mandated by regulators, such as the mining industry, aviation and construction and where high volume testing at scale for a variety of drugs and alcohol presents major challenges for management, is time consuming and expensive.

In a world first, MindBio has developed an AI model that uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice.  The technology goes further to estimate actual blood alcohol concentration levels in the successful 2025 launch of the Booze AI app, app.booze-ai.com .

The Company is developing an enterprise version and new platform level technology for health prediction using the human voice and is expanding its drug and alcohol intoxication technology for use in workplace environments, call centres, mental health and law enforcement and the Company hopes to make announcements about the progress of the new technology, new products and markets and potential commercial applications, shortly.

The Company’s CEO Justin Hanka said, “Our voice and AI powered intoxication detection technology is an exciting new non-invasive diagnostic tool that has broad implications for the detection of internal health, wellness and disease states”.

For further information, please contact:

Justin Hanka, Chief Executive Officer

61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver, British Columbia, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.  The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations.  The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

Cautionary Note Concerning Forward-Looking Statements:

The press release contains "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "budget," "believe," "project," "estimate," "expect," "scheduled," "forecast," "strategy," "future," "likely," "may," "to be," "could," "would," "should," "will" and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company's actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: general economic, market and business conditions in Canada and Australia; market volatility; unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.